- Open Access
Tools enabling the elucidation of molecular pathways active in human disease: Application to Hepatitis C virus infection
© Reiss et al; licensee BioMed Central Ltd. 2005
Received: 25 February 2005
Accepted: 20 June 2005
Published: 20 June 2005
The extraction of biological knowledge from genome-scale data sets requires its analysis in the context of additional biological information. The importance of integrating experimental data sets with molecular interaction networks has been recognized and applied to the study of model organisms, but its systematic application to the study of human disease has lagged behind due to the lack of tools for performing such integration.
We have developed techniques and software tools for simplifying and streamlining the process of integration of diverse experimental data types in molecular networks, as well as for the analysis of these networks. We applied these techniques to extract, from genomic expression data from Hepatitis C virus-infected liver tissue, potentially useful hypotheses related to the onset of this disease. Our integration of the expression data with large-scale molecular interaction networks and subsequent analyses identified molecular pathways that appear to be induced or repressed in the response to Hepatitis C viral infection.
The methods and tools we have implemented allow for the efficient dynamic integration and analysis of diverse data in a major human disease system. This integrated data set in turn enabled simple analyses to yield hypotheses related to the response to Hepatitis C viral infection.
DNA microarrays have been applied with much success to study genomic patterns of gene expression across many organisms. It has become widely acknowledged that to extract hypotheses from these data, there are advantages to the integration of orthogonal sources of information, notably, molecular-interaction data . Hypotheses derived from genomic-expression data typically involve pathways of metabolic and molecular information flow, and complex cellular processes and structures, formed by multiple interacting molecules. However, commonly these molecular interactions are gleaned ad hoc from the literature.
In model organisms such as Saccharomyces cerevisiae, integrative systems-biology approaches to genomic-expression analysis have developed and employed sophisticated methods for the computational extraction of biological knowledge. Examples include: biological module identification and abstraction ; discovery of regulatory networks [3, 4]; and identification of active pathways in networks . A hallmark of these advanced methods is the integration of diverse genome-scale data sets, in particular, the combination of genomic-expression data and molecular-interaction data. Another common characteristic of these methods is the use of graphs (vertices and edges, or nodes and links) to represent such integrated data. Graphical methods are highly intuitive. Also, the formalism of the graph facilitates the development and application of graph algorithms and machine-learning techniques to extract information.
In studies of human disease, a limited repertoire of computational techniques, including ANOVA, hierarchical clustering, and discriminant analysis, has been applied to extract information from genomic-expression data derived from human tissues. Until recently, a critical barrier has been a lack of large-scale machine-readable sources of high-quality human molecular interaction data. Using a combination of artificial-intelligence methods and expert human curation, several efforts have made substantial progress in amassing, from the literature, databases with large numbers (greater than 14000) of human molecular interactions. These include the Human Protein Reference Database (HPRD) [6, 7], the Biomolecular Interaction Network Database (BIND) [8, 9], the Database of Interacting Proteins (DIP) [10, 11], and the Transcription Factor Database (Transfac) . Thus, the bottleneck has now shifted to the efficient integration of these data to enable the application of advanced network-based analysis and modelling methods. For this work, we have implemented solutions to this bottleneck and applied them to a set of genomic-expression data derived from biopsies of human liver tissue infected with Hepatitis C Virus (HCV) . About 3% of all humans are infected with HCV , and currently no vaccine exists. Chronic viral hepatitis C results in liver fibrosis and cirrhosis in about 20% of those infected . Liver transplant is often required.
Specifically, we have developed two software tools, InteractionFetcher and CytoTalk, that function as plug-ins for Cytoscape, an open-source, platform-independent environment for the visualization and analysis of biological networks [16, 17]. InteractionFetcher and CytoTalk simplify the integration and analysis of interaction data (and other data types) with genomic-expression data. To demonstrate their utility, we applied them to generate and analyze a large network of human molecular-interaction pathways that are putatively active during the infection of human liver tissue with HCV.
InteractionFetcher, a Cytoscape plug-in
InteractionFetcher dynamically retrieves remote biological information for selected nodes in the current network within Cytoscape. The plug-in requests biological data via the XML-RPC protocol  from a remote server, which retrieves the requested information from an SQL database and passes it back to the plug-in. The plug-in then adds the retrieved information to the current network as additional nodes, edges, and/or attributes. Currently implemented data types include: protein/gene synonyms, orthologs, sequences (gene/protein/upstream), and interactions/associations. Some of this information can be obtained via integrated queries. For example, retrieved gene/protein synonym information may be used to increase the number of molecular interactions that are found. Currently-available interaction-data sets include HPRD [6, 7], BIND [8, 9], DIP [10, 11], and several other predicted interaction and co-expression data sets [19–21]. Many options are available, including the ability to do cross-species queries, using ortholog information from Homologene  among species including H. sapiens, M. musculus, S. cerevisiae, C. elegans, and D. melanogaster. For example, if two proteins in H. sapiens have not been observed to interact, but both of their orthologs in S. cerevisiae are known to interact, then an inferred interaction (also known as an interolog) can be added to the network. Moreover, the tool allows for easy viewing of the source database's web page or linked PubMed abstract(s) describing each fetched interaction. Because the source code for both the client and server of this plug-in are available, we hope that the capabilities of plug-ins such as these can be expanded by other researchers to include, for example, experimental data (such as mRNA expression levels), metabolic information, or functional annotations. Cytoscape, the InteractionFetcher and related plug-ins, plus all server-side software are open-source and may be obtained at our laboratory web site  or at the Cytoscape web site .
CytoTalk, a Cytoscape plug-in
CytoTalk enables a Cytoscape user to dynamically interact with and manipulate the current network in a Cytoscape window from an external process. This plug-in runs an internal XML-RPC  server that enables the currently-displayed network and its various attributes to be manipulated from an external client that is XML-RPC-capable. Example clients may include Perl and Python scripts, scripts written in the R statistical language , UNIX shell scripts, C or C++ programs, or Java processes. It moreover expands the developmental possibilities of Cytoscape plug-in developers by allowing other plug-ins to be written in these languages. The external process may be run on the same machine as Cytoscape, or anywhere else on an accessible network. The open-source CytoTalk and Cytoscape software as well as example CytoTalk clients in Perl, Python, and R may be obtained at our laboratory web site  or at the Cytoscape web site .
Results and discussion
For our study, we utilized expression data derived from 28 liver biopsies collected by  from 11 HCV-positive liver transplant patients, between 1 and 24 months post-transplant. Since roughly 50% of HCV+ liver transplant patients become re-infected during the two years after receiving their new livers , these biopsies provide a unique model for tracking the changes in gene expression during HCV infection . To compare gene-expression patterns in liver tissue before and after infection with HCV,  collected 28 post-transplant liver biopsies, plus pre-transplant control biopsies, from 11 HCV+ liver-transplant patients. Liver biopsies were obtained at intervals of 3 to 6 months, between 1 and 24 months post-transplant . These samples contain a mixture of cell types including hepatocytes, hepatic stellate cells, Kupffer cells (liver macrophages), in addition to various blood cells . mRNA expression ratios of about 7000 genes were measured relative to a common reference pool of pre-transplant biopsies. Using Rosetta Resolver(R) software , the data were normalized and transformed to log10 ratios, and p-values were computed for expression difference from the reference pool. The measurements showed a high degree of patient-to-patient variation. Most of the genes (5968) were significantly expressed (p <10-7) in at least one of the 28 samples. The research of  involved genomic-expression data derived from human subjects.
Construction of the molecular-interaction scaffold
Computational analysis of integrated gene-expression data and molecular-interaction data
A useful method of integrated analysis of expression data within an interaction network is the ActivePaths algorithm . This method identifies contiguous pathways or subnetworks that are active (induced or repressed relative to randomly selected subnetworks) in subsets of the expression data. We applied this algorithm, which is available as a Cytoscape plug-in, to the scaffold network. Due to the high order (number of vertices) and size (number of edges) of the scaffold network, it was necessary to iteratively apply the algorithm, as suggested by the developers, to obtain increasingly smaller active subnetworks until they contained fewer than 100 nodes. The resulting four active subnetworks contained between 40 and 121 interactions. Because there were overlaps among these four highest-scoring active subnetworks, we combined them into a single fully connected active subnetwork.
Additional analyses were performed by selecting scaffold subnetworks that are significantly active and/or co-regulated in temporal subsets of the microarray data. Because the scaffold network is not differentiated with regard to tissues, cell types, or cellular state, and the biopsy samples from which the expression data were derived likewise contain mixtures of cell types and other contaminants, the information in the active scaffold network does not, by itself, answer the questions we are addressing. To increase our chance of identifying pathways that might be modulated in response to HCV infection, we performed a differential analysis of the scaffold network, to identify subnetworks that become active more than eight months after transplant. This choice of cut-off was made to nearly-evenly divide the expression data into two halves (those from biopsies prior to, and after, eight months post-transplant), and by performing a differential analysis we can hope to subtract out some of the effects of the transplant and post-transplant immune response signals from those of HCV reinfection and progression.
We used the R statistical environment  to perform this analysis. Because R is external to Cytoscape, we developed a plug-in, called CytoTalk, that enables a user of R (or a wide variety of other environments or languages; see Methods) to interactively query and modify Cytoscape networks, thereby greatly expanding the analytical capabilities available to users of Cytoscape. We used R with CytoTalk to select the proteins and interactions implicated by specific statistical queries on the expression data. This enabled us to extract a subnetwork of genes that were significantly induced or repressed with |log10(ratio)| > 0.4 in biopsies obtained more than 8 months after transplant. The proteins encoded by these genes form a "late-active" network. We similarly extracted an "early-active" network encoded by genes that were active in biopsies obtained earlier than 8 months after transplant. We compared these two networks and identified an "only-late-active" subnetwork that was not active prior to eight months, but was active afterward. The expectation is that this "only-late-active" subnetwork will contain pathways from the "late-active" network that are activated in response to Hepatitis C virus re-infection, while pathways from the "early-active" network that may contain pathways activated as a result of the transplant are removed.
The visualization in Figure 3 enables one to identify these pathways and see whether they are "turning on" (red) or "turning off" (green) in the expression data. For example, the blood coagulation pathway is active in the expression data, although (as is to be expected with large and complex pathways) not coherently induced or repressed. The interferon-response pathway and genes activated by ISGF are clearly induced, probably due in part to the immune response to viral infection and partly in response to standard treatment of HCV-positive patients with interferon-alpha. Also, genes encoding the Toll-like receptors TLR1 and 2, as well as the downstream signalling pathway connecting them, through MYD88, to the interferon-response pathway appear to be repressed. TLRs 1 and 2 are known viral detection receptors; it is known that TLR2 detects HCV . The interleukin receptor IL1R1, upstream of MYD88, is also repressed along with other IL receptors, whereas IL1A and B are induced. Additionally, we see that many apoptosis-related genes encoding TNF, TNF receptors, and TNF-signalling factors, are activated, whereas growth factors (IGF and connected pathways), and cell cycle and translation-related pathways (e.g. CDKN and connected pathways) are repressed. Ignoring the observed responses that are likely due to by-products of the biopsy process (e.g. the blood coagulation pathway), the active pathways observed are jointly consistent with a large-scale response of complex molecular pathways to viral infection: hepatic cell reproduction is repressed and programmed cell death is induced.
Finally we note that a visual inspection of the network suggests that many of the proteins that bind directly to HCV-encoded molecules (i.e., are their first neighbours in the network) appear on average to be down-regulated relative to the rest of the network. Statistical analysis of the data supports this suggestion. As computed via CytoTalk and R, about 80% of the first neighbours of the viral RNA and proteins are down-regulated in the network of Figure 3, compared to 35% of the remaining genes in the network (p = 0.0029). This finding suggests two non-exclusive possibilities: genes encoding HCV-neighbour proteins are targets of host regulatory mechanisms counteracting viral replication; or they are targets of virus-encoded regulatory mechanisms that sabotage anti-viral defences.
The methods and software tools described here enable the efficient dynamic integrated analysis of diverse data in a major human-disease system. The results show the utility of integrating large-scale human molecular-interaction databases with genomic expression data. This approach is useful for the extraction of biological hypotheses, because it allows us to focus on groups of genes that are not only apparently active in the expression data, but are also functionally associated based on other data, such as molecular interactions. Thus, information that is not restricted to any one data type can be obtained. Moreover, our analyses suggest how various pathways act in concert, and serves as a large-scale window into the genomic response to HCV infection of liver cells. Because the tools and methods we have described are data-type-neutral, there is the prospect of further data integration for a more complete systems-biological approach to understanding viral infection and response mechanisms. The integration of additional, orthogonal sources of information such as detailed clinical data will enable quantitative associations of clinical variables with the activities of molecular pathways and processes.
Availability and requirements
Project name: InteractionFetcher, SynonymFetcher, HomologFetcher, and CytoTalk: plug-ins for Cytoscape
Project home page: http://labs.systemsbiology.net/galitski/hepc/
Operating system(s): Platform independent
Programming language: Java
Other requirements: Java 1.4 or higher
License: GNU LGPL
Any restrictions to use by non-academics: license required for access to HPRD interactions (see )
The authors would like to thank Maria Smith, Matt Fitzgibbon and Michael Katze for early access to the biopsy data. We would also like to gratefully acknowledge Paul Shannon and Rowan Christmas for their assistance with Cytoscape, Eric Deutsch for his support with data management and processing, and Akhilesh Pandey and Babylaksmi Muthusamy for their help in providing the HPRD interactions in a machine-readable format. We would also like to thank Wei Yan for helpful discussions. This project was funded by the National Institute on Drug Abuse, grant number 1P30DA01562501.
- Galitski T: Molecular networks in model systems. Annu Rev Genomics Hum Genet 2004, 5: 177–87. 10.1146/annurev.genom.5.061903.180053View ArticlePubMedGoogle Scholar
- Prinz S, Avila-Campillo I, Aldridge C, Srinivasan A, Dimitrov K, Siegel AF, Galitski T: Control of yeast filamentous-form growth by modules in an integrated molecular network. Genome Res 2004, 14(3):380–90. 10.1101/gr.2020604PubMed CentralView ArticlePubMedGoogle Scholar
- Bar-Joseph Z, Gerber GK, Lee TI, Rinaldi NJ, Yoo JY, Robert F, Gordon DB, Fraenkel E, Jaakkola TS, Young RA, Gifford DK: Computational discovery of gene modules and regulatory networks. Nat Biotechnol 2003, 21(11):1337–42. Epub 2003 Oct 12 10.1038/nbt890View ArticlePubMedGoogle Scholar
- Segal E, Yelensky R, Koller D: Genome-wide discovery of transcriptional modules from DNA sequence and gene expression. Bioinformatics 2003, 19(Suppl 1):i273–82. 10.1093/bioinformatics/btg1038View ArticlePubMedGoogle Scholar
- Ideker T, Ozier O, Schwikowski B, Siegel AF: Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 2002, 18(Suppl 1):S233–40.View ArticlePubMedGoogle Scholar
- Peri S, Navarro JD, Kristiansen TZ, Amanchy R, Surendranath V, Muthusamy B, Gandhi TK, Chandrika KN, Deshpande N, Suresh S, Rashmi BP, Shanker K, Padma N, Niranjan V, Harsha HC, Talreja N, Vrushabendra BM, Ramya MA, Yatish AJ, Joy M, Shivashankar HN, Kavitha MP, Menezes M, Choudhury DR, Ghosh N, Saravana R, Chandran S, Mohan S, Jonnalagadda CK, Prasad CK, Kumar-Sinha C, Deshpande KS, Pandey A: Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res 32(Database):D497–501. 2004 Jan 1Google Scholar
- Human Protein Reference Database[http://www.hprd.org]
- Bader GD, Betel D, Hogue CW: BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res 2003, 31(1):248–50. 10.1093/nar/gkg056PubMed CentralView ArticlePubMedGoogle Scholar
- Biomolecular Interaction Network Database[http://bind.ca]
- Salwinski L, Miller CS, smit AJ, Pettit FK, Bowie JU, Eisenberg D: The Database of Interacting Proteins: 2004 update. NAR 2004, 32(Database):D449–51. 10.1093/nar/gkh086PubMed CentralView ArticlePubMedGoogle Scholar
- Database of Interacting Proteins[http://dip.doe-mbi.ucla.edu]
- Krull M, Voss N, Choi C, Pistor S, Potapov A, Wingender E: TRANSPATH: an integrated database on signal transduction and a tool for array analysis. Nucleic Acids Res 31(1):97–100. 2003 Jan 1 10.1093/nar/gkg089Google Scholar
- Smith MW, Yue ZN, Do HA, Netski D, Boix L, Bruix J, Thomas DL, Carithers RL Jr, Katze MG, in press.Google Scholar
- Wasley A, Alter MJ: Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000, 20(1):1–16. Review 10.1055/s-2000-9506View ArticlePubMedGoogle Scholar
- Alter HJ, Seeff LB: Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000, 20(1):17–35. Review 10.1055/s-2000-9505View ArticlePubMedGoogle Scholar
- Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13(11):2498–504. 10.1101/gr.1239303PubMed CentralView ArticlePubMedGoogle Scholar
- XML-RPC Specification[http://www.XML-RPC.com]
- Lehner B, Fraser AG: A first-draft human protein-interaction map. Genome Biol 2004, 5(9):R63. Epub 2004 Aug 13 10.1186/gb-2004-5-9-r63PubMed CentralView ArticlePubMedGoogle Scholar
- Stuart JM, Segal E, Koller D, Kim SK: A gene-coexpression network for global discovery of conserved genetic modules. Science 302(5643):249–55. 2003 Oct 10, Epub 2003 Aug 21 10.1126/science.1087447Google Scholar
- Lee HK, Hsu AK, Sajdak J, Qin J, Pavlidis P: Coexpression analysis of human genes across many microarray data sets. Genome Res 2004, 14(6):1085–94. 10.1101/gr.1910904PubMed CentralView ArticlePubMedGoogle Scholar
- Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, Church DM, DiCuccio M, Edgar R, Federhen S, Helmberg W, Kenton DL, Khovayko O, Lipman DJ, Madden TL, Maglott DR, Ostell J, Pontius JU, Pruitt KD, Schuler GD, Schriml LM, Sequeira E, Sherry ST, Sirotkin K, Starchenko G, Suzek TO, Tatusov R, Tatusova TA, Wagner L, Yaschenko E: Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 33(Database):D39–45. 2005 Jan 1 10.1093/nar/gki062Google Scholar
- The R Project for Statistical Computing[http://www.r-project.org]
- Berenguer M: Natural history of recurrent hepatitis C. Liver Transpl 2002, 8(Suppl 1):S14-S18. 10.1053/jlts.2002.35781View ArticlePubMedGoogle Scholar
- Stoughton R, Dai H: Statistical combining of cell expression profiles. US Patent 6351712 2002.Google Scholar
- Tellinghuisen TL, Rice CM: Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol 2002, 5(4):419–27. Review 10.1016/S1369-5274(02)00341-7View ArticlePubMedGoogle Scholar
- Polyak SJ: Hepatitis C virus – cell interactions and their role in pathogenesis. Clin Liver Dis 2003, 7(1):67–88. Review 10.1016/S1089-3261(02)00075-2View ArticlePubMedGoogle Scholar
- Samuel CE: Antiviral actions of interferons. Clin Microbiol Rev 2001, 14: 778–809. 10.1128/CMR.14.4.778-809.2001PubMed CentralView ArticlePubMedGoogle Scholar
- Maglott D, Ostell J, Pruitt KD, Tatusova T: Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 33(Database):D54–8. 2005 Jan 1 10.1093/nar/gki031Google Scholar
- Entrez Gene[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene]
- Donaldson I, Martin J, de Bruijn B, Wolting C, Lay V, Tuekam B, Zhang S, Baskin B, Bader GD, Michalickova K, Pawson T, Hogue CW: PreBIND and Textomy – mining the biomedical literature for protein-protein interactions using a support vector machine. BMC Bioinformatics 4(1):11. 2003 Mar 27 10.1186/1471-2105-4-11Google Scholar
- Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25(1):25–9. 10.1038/75556PubMed CentralView ArticlePubMedGoogle Scholar
- Gene Ontology Consortium[http://www.geneontology.org]
- Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G: Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004, 127(5):1513–24.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.